Dopamine, norepinephrine and serotonin transporter gene deletions differentially alter cocaine-induced taste aversion

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 4, 2010, Pages 580-587

  Jones, Jermaine D ^a   Hall, F Scott ^b   Uhl, George R ^b   Riley, Anthony L ^a  

^a AMERICAN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cocaine; DAT; Knockout; Monoamine; NET; SERT; Taste aversion

Indexed keywords

COCAINE; DOPAMINE TRANSPORTER; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE DELETION; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASTE AVERSION; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; AVOIDANCE LEARNING; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TASTE;

MUS; MUS MUSCULUS;

EID: 74249101057     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.11.014     Document Type: Article

References (70)

1. Anthony J.C., Tien A.Y., and Petronis K.R. Epidemiological evidence on cocaine use and panic attack. Am J Epidemiol 129 (1989) 543-549
2. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., Mossner R., Westphal H., and Lesch K.P. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53 (1998) 649-655
3. Benoit-Marand M., Jaber M., and Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J NeuroSci 12 (2000) 2985-2992
4. Blanchard D.C., and Blanchard R.J. Cocaine potentiates the defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23 (1999) 981-991
5. Busse G.D., Freeman K.B., and Riley A.L. The interaction of sex and route of administration in cocaine-induced taste aversion. Pharmacol Biochem Behav 81 (2005) 814-820
6. Carey R.J., DePalma G., Damianopoulos E., Shanahan A., Müller C.P., and Huston J.P. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res 1034 (2005) 162-171
7. Chen R., Tilley M.R., Wei H., Zhou F., Zhou F.M., Ching S., Quan N., Stephens R.L., Hill E.R., Nottoli T., Han D.D., and Gu H.H. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter. Proc Natl Acad Sci U S A 103 (2006) 9333-9338
8. Cordero-Erausquin M., Marubio L.M., Klink R., and Changeux J.P. Nicotinic receptor function: new perspectives from knockout mice. Trends Pharmacol Sci 21 (2000) 211-217
9. de Bruin N., Mahieu M., Patel T., Willems R., Lesage A., and Megens A. Performance of F2 B6x129 hybrid mice in the Morris water maze, latent inhibition and prepulse inhibition paradigms: comparison with C57Bl/6J and 129sv inbred mice. Behav Brain Res 172 (2006) 122-134
10. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 (2004) 227-241
11. Dziedzicka-Wasylewska M., Faron-Górecka A., Kuśmider M., Drozdowska E., Rogóz Z., Siwanowicz J., Caron M.G., and Bönisch H. Effect of antidepressant drugs in mice lacking the norepinephrine transporter. Neuropsychopharmacology 31 (2006) 2424-2432
12. Estelles J., Rodriquez-Arias M., Aquilar M.A., and Minarro J. Social behavioral profile of cocaine in isolated and group male mice. Drug Alcohol Depend 76 (2004) 115-123
13. Ettenberg A., and Geist T.D. Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology (Berl) 103 (1991) 455-461
14. Fabre V., Beaufour C., Evrard A., Riouux A., Hanoun N., Lesch K.P., Murphy D.L., Lanfumey L., Hamon M., and Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the dopamine transporter. Eur J NeuroSci 12 (2000) 19-26
15. Freeman K.B., Konaklieva M.I., and Riley A.L. Assessment of the contributions of Na+ channel inhibition and general peripheral action in cocaine-induced taste aversion. Pharmacol Biochem Behav 80 (2005) 281-288
16. Freeman K.B., Rice K.C., and Riley A.L. Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion. Pharmacol Biochem Behav 82 (2005) 583-589
17. Freeman K.B., Verendeev A., and Riley A.L. Noradrenergic antagonism enhances the conditioned aversive effects of cocaine. Pharmacol Biochem Behav 88 (2008) 523-532
18. Gainetdinov R.R., and Caron M.G. Monoamine transporters: from genes to behavior. Ann Rev Pharmacol Toxicol 43 (2003) 261-284
19. Garcia J., Kimeldorf D.J., and Koelling R.A. Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science 122 (1955) 157-158
20. Giros B., Jaber M., Jones S.R., Wightman R.M., and Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379 (1996) 606-612
21. Goudie A.J., and Thornton E.W. Effects of drug experience on drug induced conditioned taste aversions: studies with amphetamine and fenfluramine. Psychopharmacologia 44 (1975) 77-82
22. Grupp L.A. Effects of pimozide on the acquisition, maintenance, and extinction of an amphetamine-induced taste aversion. Psychopharmacology (Berl) 53 (1997) 235-242
23. Hall F.S., Sora I., and Uhl G.R. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 154 (2001) 43-49
24. Hall F.S., Li X., Sora I., Xu F., Caron M., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine mechanism: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions. Neuroscience 115 (2002) 153-161
25. Hall F.S., Sora I., Drgonova J., Li X.F., Goeb M., and Uhl G.R. Molecular mechanism underling the rewarding effects of cocaine. Ann N Y Acad Sci 1025 (2004) 47-56
26. Hall F.S., Li X.F., Randall-Thompson J., Sora I., Murphy D.L., Lesch K.P., Caron M., and Uhl G.R. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice. Neuroscience 162 (2009) 870-880
27. Holmes A., Lit Q., Murphy D.L., Gold E., and Crawley J.N. Abnormal anxiety-like behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2 (2003) 365-380
28. Holmes A., Murphy D.L., and Crawley J.N. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety behavior. Biol Psychiatry 54 (2003) 953-959
29. Holmes A., Yang R.J., Murphy D.L., and Crawley J.N. Evaluation of antidepressant-related behavioral response in mice lacking the serotonin transporter. Neuropsychopharmacology 27 (2002) 914-923
30. Jones S.R., Gainetdinov R.R., Hu X.T., Cooper D.C., Wightman R.M., White F.J., and Caron M.G. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nat Neurosci 2 (1999) 649-655
31. Jones J.D., Hall F.S., Uhl G.R., Rice K., and Riley A.L. Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion. Pharmacol Biochem Behav 93 (2009) 75-81
32. Kalueff A.V., Fox M.A., Gallagher P.S., and Murphy D.L. Hypolocomotion anxiety and serotonin syndrome-like behavioral contribute to the complex phenotype of serotonin transporter Knockout mice. Genes Brain Behav 6 (2006) 389-400
33. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., Holmes A., Lesch K.P., and Murphy D.L. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49 (2005) 798-810
34. Koob G.F., Caine B., Parsons L., Markou A., and Weiss F. Opponent process model of psychostimulant addition. Pharmacol Biochem Behav 57 (1997) 514-527
35. Kuhar M.J., Ritz M.C., and Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14 (1991) 299-330
36. Lynch W.J., and Carroll M.E. Regulation of drug intake. Exp Clin Psychopharmacol 9 (2001) 131-143
37. McDougle C.J., Black J.E., Malison R.T., Zimmermann R.C., Kosten T.R., Heninger G.R., and Price L.H. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry 51 (1994) 713-719
38. Medvedev I.O., Gainetdinov R.R., Sotnikova T.D., Bohn L.M., Caron M.G., and Dykstra L.A. Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice. Psychopharmacology (Berl) 180 (2005) 408-413
39. Mokrani M.C., Duval F., Croca M.A., Bailey P., and Macher J.P. HPA axis dysfunction in depression: correlation with monoamine system abnormalities. Psychoneuroendocrinology 22 (1997) 63-68
40. Miner L.L., Drago J., Chamberlain P.M., Donovan D., and Uhl G.R. Retained cocaine conditioned place preference in D1 receptor deficient mice. NeuroReport 6 (1995) 2314-2316
41. National Research Council. Guide for the case and use of laboratory animals (1996), National Academy Press, Washington, DC
42. National Research Council. Guide for the case and use of mammals in behavioral and neuroscience research (2003), National Academy Press, Washington, DC
43. Pan Y.X., Xu J., Xu M., Rossi G.C., Matulonis J.E., and Pasternak G.W. Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions. Proc Natl Acad Sci U S A 106 (2009) 4917-4922
44. Parsons L.H., Weiss F., and Koob G.F. Serotonin1B receptor stimulation enhances cocaine reinforcement. J. Neurosci. 18 (1998) 10078-10089
45. Pattij T., Broersen L.M., van der Linde J., Groenink L., van der Gugten J., Maes R.A., and Olivier B. Operant learning and differential-reinforcement-of-low-rate 36-s responding in 5-HT1A and 5-HT1B receptor knockout mice. Behav Brain Res 141 (2003) 137-145
46. Perona M.T., Waters S., Hall F.S., Sora I., Lesch K.P., Murphy D.L., Caron M., and Uhl G.R. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav Pharmacol 19 (2008) 566-574
47. Pruitt D.L., Bolanos C.A., and McDougall S.A. Effects of D1 and D2 receptor antagonists on cocaine-induced place preference in preweaning rats. Eur J Pharmacol 283 (1995) 125-131
48. Randall-Thompson J.F. Characterization of dopamine and serotonin in concurrently conditioned taste aversion and place preferences. Dissertation Abstracts International 2005.
49. Riley A.L., and Simpson G.R. The attenuating effects of drug preexposure on taste aversion conditioning: generality, experimental parameters, underlying mechanism and implications for drug use and abuse. In: Mower R.R., and Klein S.B. (Eds). Contemporary learning theory. 2nd Edition (2001), Lawernce Erlbaum Associates, Hillsdale, NJ 505-559
50. Riley A.L., and Tuck D.L. Conditioned taste aversions: a behavioral index of toxicity. Ann N Y Acad Sci 443 (1985) 272-292
51. Roberts D.C., and Fibiger H.C. Attenuation of amphetamine-induced conditioned taste aversion following intraventricular 6-hydroxydopamine. Neurosci Lett 1 (1975) 343-347
52. Rocha B.A. Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice. Eur J Pharmacol 479 (2003) 107-115
53. Rocha B.A., Fumangalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., and Caron M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nat Neurosci 1 (1998) 132-137
54. Rocha B.A., Odom L.A., Barron B.A., Ator R., Wild S.A., and Forester M.J. Differential responsiveness to cocaine in C57BL/6J and DBA/2J mice. Psychopharmacology 138 (1998) 82-88
55. Rocha B.A., Goulding E.H., O'Dell L.E., Mead A.N., Coufal N.G., Parsons L.H., and Tecott L.H. Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice. J Neurosci 22 (2002) 10039-10045
56. Rosen M.I., and Kosten T.A. Cocaine-associated panic attacks in methadone-maintained patients. Am J Drug Alcohol Abuse 18 (1992) 57-62
57. Serafine K.M., and Riley A.L. Possible role of norepinephrine in cocaine-induced taste aversion. Pharmacol Biochem Behav 92 (2009) 111-116
58. Shippenberg T.S., Bals-Kubik R., and Herz A. Examination of the neurochemical substrates mediating the motivations effects of opioid: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J Pharmacol Exp Ther 265 (1993) 53-59
59. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., Lesch K.P., and Uhl G.R. Cocaine reward models: conditioned place preference can be established in dopamine and serotonin transporter knockout mice. Proc Natl Acad Sci USA 95 (1998) 7699-7704
60. Sora I., Hall F.S., Andrews A.M., Itokawa M., Li X.F., Wei H.B., Wichems C., Lesch K.P., Murphy D.L., and Uhl G.R. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci USA 98 (2001) 5003-5005
61. Stolerman I.P., and D'Mello G.D. Role of training conditions in discrimination of central nervous system stimulants by rats. Psychopharmacology (Berl) 73 (1981) 295-303
62. Taylor D., and Ho B.T. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol 21 (1978) 67-73
63. Thomsen M., Hall F.S., Uhl G.R., and Caine S.B. Dramatically decrease cocaine self administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29 (2009) 1087-1092
64. Tzavara E.T., Degroot A., Wade M.R., Davis R.J., and Nomikos G.G. CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: role of mGlu5 receptors. Eur Neuropsychopharmacol 19 (2009) 196-204
65. Uhl G.R., Hall F.S., and Sora I. Cocaine, reward movement and monoamine transporters. Mol Psychiatry 7 (2002) 21-26
66. Wellman C.l., Izquierdo A., Garrett J.E., Martin K.P., Carroll J., Millstein R., Lesch K.P., Murphy D.L., and Holmes A. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin knockout transporter knock-out mice. J Neurosci 27 (2007) 684-691
67. Woolverton W.L., and Kleven M.S. Multiple dopamine receptors and the behavioral effects of cocaine. NIDA Res Monogr 88 (1988) 160-184
68. Xu M., Guo Y., Vorhees C.V., and Zhang J. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res 852 (2000) 198-207
69. Xu F., Gainetdinov R.R., and Wetsel W.C. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3 (2000) 465-471
70. Yang X.M., Gorman A.l., Dunn A.J., and Goeders N.E. Anxiogenic effects of acute and chronic cocaine administration: neurochemical and behavioral studies of. Pharmacol Biochem Behav 41 (1992) 643-650